Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1403050

GTEX

b11ac068-5243-565d-a2ea-36be695f5b72

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • KRAS_SIGNALING_DN+0.372
  • SPERMATOGENESIS+0.363
  • PANCREAS_BETA_CELLS+0.208
  • HEDGEHOG_SIGNALING+0.092
  • UV_RESPONSE_DN+0.072
  • MYOGENESIS+0.044
  • ESTROGEN_RESPONSE_LATE-0.018
  • OXIDATIVE_PHOSPHORYLATION-0.025
  • ESTROGEN_RESPONSE_EARLY-0.027
  • BILE_ACID_METABOLISM-0.030

Top 10 suppressed

  • CHOLESTEROL_HOMEOSTASIS-0.548
  • INTERFERON_ALPHA_RESPONSE-0.534
  • MYC_TARGETS_V1-0.518
  • IL6_JAK_STAT3_SIGNALING-0.463
  • DNA_REPAIR-0.456
  • UNFOLDED_PROTEIN_RESPONSE-0.453
  • E2F_TARGETS-0.452
  • MTORC1_SIGNALING-0.440
  • INTERFERON_GAMMA_RESPONSE-0.435
  • G2M_CHECKPOINT-0.424

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1487107
brain-umap@2
GTEX0.978
2SRR1403831
brain-umap@2
GTEX0.976
3SRR1357021
brain-umap@2
GTEX0.973
4SRR1336357
brain-umap@2
GTEX0.968
5SRR1432343
brain-umap@2
GTEX0.967
6SRR1406561
brain-umap@2
GTEX0.965
7SRR1476676
brain-umap@2
GTEX0.960
8SRR1413625
brain-umap@2
GTEX0.955
9SRR1466850
brain-umap@2
GTEX0.955
10SRR1361567
brain-umap@2
GTEX0.953

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 6 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_DN0.372Remibrutinib— uncovered
SPERMATOGENESIS0.363Inavolisib— uncovered
PANCREAS_BETA_CELLS0.208Cobimetinib— uncovered
HEDGEHOG_SIGNALING0.092Inavolisib— uncovered
UV_RESPONSE_DN0.072Inavolisib— uncovered
MYOGENESIS0.044Inavolisib— uncovered